The Year 2025: A Turning Point for Flu Deaths
The Australia Bureau of Statistics has revealed a startling trend: 2025 saw the highest number of flu-related deaths this century, surpassing even the peak of the COVID-19 pandemic. This alarming statistic highlights the evolving nature of respiratory diseases and the importance of understanding the factors driving these fluctuations.
But what's behind this dramatic rise? The answer lies in the emergence of a new flu variant, H3N2 Subclade K, which has significantly contributed to the increased mortality rates. According to epidemiologist Catherine Bennett, this variant possessed unique mutations that rendered the existing vaccine and prior immunity less effective.
The Impact of Subclade K
Professor Bennett explains that the Subclade K strain extended the flu season into the summer months, a period typically associated with lower flu activity. This extended seasonality had a profound impact on the overall death toll, as evidenced by the sharp contrast between the summer and winter peaks.
COVID-19's Decline and Flu's Rise
While COVID-19 deaths experienced a significant decline in 2025, with the number of fatalities falling by more than half compared to 2024, the flu made a dramatic comeback. The second peak in summer 2025 saw a staggering 741 influenza deaths, compared to 428 COVID-related deaths, marking a notable shift in the landscape of respiratory infections.
The Summer Flu Paradox
Interestingly, the summer flu peak is not always a given. Professor Bennett notes that while 2025 saw a surge in flu deaths, other years like 2017 had similar summer spikes. This variability underscores the complex interplay of factors influencing flu activity, including vaccination rates and the emergence of new variants.
Vaccination: A Key to Mitigation
Despite the challenges posed by the Subclade K variant, Professor Bennett emphasizes the importance of vaccination in mitigating the impact of flu. While the vaccine may not prevent infection, it significantly reduces the severity of the disease and the likelihood of death. This is particularly crucial for vulnerable populations, such as those over the age of 70, who account for the majority of flu-related deaths.
A Call for Action
The data highlights a pressing need for increased vaccination rates, especially among the elderly. Only about 60% of people over 65 are covered by the flu vaccine, leaving a significant portion vulnerable to severe disease and death. By addressing this gap, we can potentially reduce the overall burden of respiratory diseases and save lives.
